Form 4: VolitionRx COO Gaetan Michel Reports Stock Award Vesting and Cancellation

Chief Operating Officer of VolitionRx, Gaetan Michel, reports vesting of restricted stock units and cancellation of unvested units.

Summary

• Gaetan Michel, the Chief Operating Officer of VolitionRx, reported a transaction involving restricted stock units (RSUs).
• On August 15, 2024, 25,250 RSUs vested due to the achievement of certain corporate performance goals.
• These RSUs are part of an award of 101,000 RSUs granted on September 28, 2023, under the company's 2015 Stock Incentive Plan.
• The vested RSUs are subject to a 3-year time-based vesting schedule, with installments vesting on September 28, 2024, 2025, and 2026.
• Additionally, 32,825 RSUs that did not meet performance goals were cancelled on August 15, 2024.
• Following the reported transaction, Michel directly owns 379,449 shares of common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. While some RSUs vested, indicating achievement of performance goals, others were cancelled, suggesting some goals were not met. The overall impact is balanced.

Positives

• The vesting of RSUs indicates that certain corporate performance goals were achieved.

Negatives

• The cancellation of 32,825 RSUs suggests that some performance goals were not met.

Future Outlook

The vested RSUs will continue to vest in installments on September 28, 2024, 2025, and 2026.

Industry Context

This filing is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into the compensation and equity ownership of key executives.

Stakeholder Impact

• The vesting and cancellation of RSUs may have a minor impact on shareholder equity.
• The vesting of RSUs could be seen as a positive sign for employees, indicating that performance goals are being met.

Key Dates